Identification of Kininogen-1 as a Serum Biomarker for the Early Detection of Advanced Colorectal Adenoma and Colorectal Cancer

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Wang, Jing ^a,b   Wang, Xinying ^a,b   Lin, Shiyong ^c   Chen, Chudi ^a,b   Wang, Congrong ^a   Ma, Qunying ^a,b   Jiang, Bo ^a,b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Guangdong Provincial Key Laboratory of Gastroenterology   (China)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

KININOGEN; KININOGEN I; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER SCREENING; CANCER STAGING; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; BRAIN MAPPING; CASE-CONTROL STUDIES; CELL PHYSIOLOGICAL PHENOMENA; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GLUCOSE; HUMANS; LONGITUDINAL STUDIES; MALE; MICE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEURAL NETWORKS (COMPUTER); NEUROIMAGING; POSITRON-EMISSION TOMOGRAPHY; RATS;

EID: 84880705235     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070519     Document Type: Article

References (34)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62 (1): 10-29.
2. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, et al. (2010) Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375 (9726): 1624-1633.
3. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, et al. (2010) Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116 (3): 544-573.
4. van Rossum LG, (2012) Colorectal cancer screening: how to stop a moving target. Clin Gastroenterol Hepatol 10 (6): 570-572.
5. Sung JJ, Lau JY, Young GP, Sano Y, Chiu HM, et al. (2008) Asia Pacific consensus recommendations for colorectal cancer screening. Gut 57 (8): 1166-1176.
6. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, (2004) Ross ME; Colorectal Cancer Study Group (2004) Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 351 (26): 2704-2714.
7. Collins JF, Lieberman DA, Durbin TE, Weiss DG; Veterans Affairs Cooperative Study #380 Group (2005) Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with ecommended sampling practice. Ann Intern Med 142 (2): 81-85.
8. Roessler M, Rollinger W, Palme S, Hagmann ML, Berndt P, et al. (2005) Identification of Nicotinamide N-Methyltransferase as a Novel Serum Tumor Marker for Colorectal Cancer. Clin Cancer Res 11 (18): 6550-6557.
9. Teng PN, Bateman NW, Hood BL, Conrads TP, (2010) Advances in proximal fluid proteomics for disease biomarker discovery. J Proteome Res 9 (12): 6091-6100.
10. Prudent M, Tissot JD, Lion N, (2011) Proteomics of blood and derived products: what's next? Expert Rev Proteomics 8 (6): 717-737.
11. Kojima K, Asmellash S, Klug CA, Grizzle WE, Mobley JA, et al. (2008) Applying Proteomic-Based Biomarker Tools for the Accurate Diagnosis of Pancreatic Cancer. J Gastrointest Surg 12: 1683-1690.
12. Liu W, Gao X, Cai Q, Li J, Zhu Z, et al. (2010) Identification of novel serum biomarkers for gastric cancer by magnetic bead. Front Biosci (Elite Ed) 2: 961-971.
13. Freed GL, Cazares LH, Fichandler CE, Fuller TW, Sawyer CA, et al. (2008) Differential Capture of Serum Proteins for Expression Profiling and Biomarker Discovery in Pre- and Post-treatment Head and Neck Cancer Samples. Laryngoscope 118 (1): 61-68.
14. Solassol J, Jacot W, Lhermitte L, Boulle N, Maudelonde T, et al. (2006) Clinical proteomics and mass spectrometry profiling for cancer detection. Expert Rev Proteomics 3 (3): 311-320.
15. Umemura H, Togawa A, Sogawa K, Satoh M, Mogushi K, et al. (2011) Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis. J Gastroenterol 46 (5): 577-585.
16. Seraglia R, Molin L, Tonidandel L, Pucciarelli S, Agostini M, et al. (2007) An investigation on the nature of the peptide at m/z 904, overexpressed in plasma of patients with colorectal cancer and familial adenomatous polyposis. J Mass Spectrom 42 (12): 1606-1612.
17. Colman R W, (1999) Biologic activities of the contact factors in vivo: potentiation of hypotension, inflammation, and fibrinolysis, and inhibition of cell adhesion, angiogenesis and thrombosis. Thromb Haemost 82 (6): 1568-1577.
18. George M Yousef, Eleftherios P Diamandis, (2001) The New Human Tissue Kallikrein Gene Family:Structure, Function, and Association to Disease. Endocr Rev 22 (2): 184-204.
19. Wark PA, Wu K, van't Veer P, Fuchs CF, Giovannucci EL, (2009) Family history of colorectal cancer: a determinant of advanced adenoma stage or adenoma multiplicity? Int J Cancer 125 (2): 413-420.
20. Wang J, Wang X, Gong W, Mi B, Liu S, et al. (2009) Increased Expression of β-catenin, Phospho-Glycogen Synthase Kinase 3β, cyclinD1 and c-myc in Laterally Spreading Colorectal Tumors. J Histochem Cytochem 57 (4): 363-371.
21. Chinello C, Gianazza E, Zoppis I, Mainini V, Galbusera C, et al. (2010) Serum biomarkers of renal cell carcinoma assessed using a protein profiling approach based on Clinprot technique. Urology 75 (4): 842-847.
22. Jou YJ, Lin CD, Lai CH, Tang CH, Huang SH, et al. (2011) Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages. Clin Chim Acta 412 (15-16): 1357-1365.
23. Tolson JP, Flad T, Gnau V, Dihazi H, Hennenlotter J, et al. (2006) Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis. Proteomics 6 (2): 697-708.
24. Chang JT, Chen LC, Wei SY, Chen YJ, Wang HM, et al. (2006) Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry-plasma peptidomes from nasopharyngeal cancer patients for example. Clin Biochem 39 (12): 1144-1151.
25. Kawasaki M, Maeda T, Hanasawa K, Ohkubo I, Tani T, (2003) Effect of His-Gly-Lys motif derived from domain 5 of high molecular weight kininogen on suppression of cancer metastasis both in vitro and in vivo. J Biol Chem 278 (49): 49301-49307.
26. Abdullah-Soheimi SS, Lim BK, Hashim OH, Shuib AS, (2010) Patients with ovarian carcinoma excrete different altered levels of urine CD59, kininogen-1 and fragments of inter-alpha-trypsin inhibitor heavy chain H4 and albumin. Proteome Sci 8: 58.
27. Liu Y, Cao DJ, Sainz IM, Guo YL, Colman RW, (2008) The inhibitory effect of Hka in endothelial cell tube formation is mediated by disrupting the uPAuPAR complex and inhibiting its signaling and internalization. Am J Physiol Cell Physiol 295 (1): C257-267.
28. Abdul-Rahman PS, Lim BK, Hashim OH, (2007) Expression of high-abundance proteins in sera of patients with endometrial and cervical cancers: Analysis using 2-DE with silver staining and lectin detection methods. Electrophoresis 28 (12): 1989-1996.
29. Brenner H, Haug U, Arndt V, Stegmaier C, Altenhofen L, et al. (2010) Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy. Gastroenterology 138 (3): 870-876.
30. Qiu Y, Patwa TH, Xu L, Shedden K, Misek DE, et al. (2008) Plasma Glycoprotein Profiling for Colorectal Cancer Biomarker Identification by Lectin Glycoarray and Lectin Blot. J Proteome Res 7 (4): 1693-1703.
31. Roeise O, Sivertsen S, Ruud TE, Bouma BN, Stadaas JO, et al. (1990) Studies on components of the contact phase system in patients with advanced gastrointestinal cancer. Cancer 65 (6): 1355-1359.
32. Sturgeon CM, Duffy MJ, Stenman UH, Lilja H, Brünner N, et al. (2008) National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem 54 (12): e11-79.
33. Goldstein MJ, Mitchell EP, (2005) Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest 23 (4): 338-351.
34. Anonymous (1996) Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology. J Clin Oncol 14 (10): 2843-2877.